Nabriva Therapeutics plc

NBRV | $1.42 1.39% 720K

(0.0% 1d) (0.0% 1m) (-13.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3702.73% volume)
Earnings Calendar: 2023-08-03
Market Cap: $ 4,546,068
http://www.nabriva.com
Sec Filling | Patents | 162 employees

(IE) Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

antibiotics pleuromutilin antibiotic antibacterial injection

add to watch list Paper trade email alert is off

Perrigo Company

PRGO | $30.22 0.94% 140K

Health Technology

(0.0% 1d) (-4.0% 1m) (-16.3% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 4,095,291,677
http://www.perrigo.com
Sec Filling | Patents | 11200 employees

(IE) Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

israel brands diagnostics

Drugs

ESTRADIOL VALERATE (ESTRADIOL VALERATE)

add to watch list Paper trade email alert is off

Jazz Pharmaceuticals plc

JAZZ | $109.03 -0.22% 66K

Health Technology

(0.0% 1d) (-14.2% 1m) (-26.1% 1y) (0.0% 2d) (0.0% 3d) (-3.4% 7d) (8.63% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 6,868,890,000
http://www.jazzpharma.com
Sec Filling | Patents | 1620 employees

(IE) Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

urea narcolepsy msa

Drugs

DEFITELIO (defibrotide sodium)
ERWINAZE (Asparaginase)
FazaClo (clozapine)
Prialt (ziconotide)
SUNOSI (solriamfetol)
VYXEOS ((daunorubicin and cytarabine) liposome)
Xyrem (sodium oxybate)
XYWAV ((calcium, magnesium, potassium, and sodium oxybates))
ZEPZELCA (Lurbinectedin)

add to watch list Paper trade email alert is off

Trinity Biotech plc

TRIB | $1.88 210

Health Technology

(0.0% 1d) (-16.4% 1m) (61.4% 1y) (0.0% 2d) (0.0% 3d) (-3.7% 7d) (-88.03% volume)
Earnings Calendar:
Market Cap: $ 4,245,100
http://www.trinitybiotech.com
Sec Filling | Patents | n/a employees

(IE) Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

diagnostics

add to watch list Paper trade email alert is off

Amarin Corporation plc

AMRN | $0.8761 0.49% 360K

Health Technology

(0.0% 1d) (3.6% 1m) (-31.7% 1y) (0.0% 2d) (0.0% 3d) (1.1% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 86,560,416
http://amarincorp.com
Sec Filling | Patents | 965 employees

(IE) Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

cardiovascular marine vascepa

add to watch list Paper trade email alert is off

Prothena Corporation plc

PRTA 4 | $20.91 1.65% 210K

Health Technology

(0.0% 1d) (-17.7% 1m) (-60.3% 1y) (0.0% 2d) (0.0% 3d) (-4.5% 7d) (-2.96% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 1,123,294,714
http://www.prothena.com
Sec Filling | Patents | 51 employees

(IE) Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

add to watch list Paper trade email alert is off

Avadel Pharmaceuticals plc

AVDL | $17.55 0.98% 620K

Health Technology

(0.0% 1d) (4.9% 1m) (75.9% 1y) (0.0% 2d) (0.0% 3d) (-3.9% 7d) (-52.15% volume)
Earnings Calendar:
Market Cap: $ 0
http://www.avadel.com
Sec Filling | Patents | 50 employees

(IE) Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

ft218 narcolepsy

add to watch list Paper trade email alert is off

ICON plc

ICLR | $288.325 -1.2% 170K

Health Technology

(0.0% 1d) (-13.0% 1m) (41.6% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (-42.16% volume)
Earnings Calendar:
Market Cap: $ 23,785,395,671
http://www.iconplc.com
Sec Filling | Patents | 14650 employees

(IE) ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

msa

add to watch list Paper trade email alert is off